CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
07/30/2026
Back to search
Official data from USPTO
CAVACURMIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CAVACURMIN
ST13
US500000079176088Class
1, 5, 29, 30, 40
Filing
79176088
Registration
5445399
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
65
Latest update
07/30/2026
Trademark type
Word
Nice classes
1, 5, 29, 30, 40
Filing date
09/03/2015
Registration date
04/17/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/21/2024
Last transaction
07/30/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Munich, DE
Examiner
BAL, KAMAL SINGH
Current location
Historical data usage
Holders and representatives
Holders
Wacker Chemie AG
Wacker Chemie AG
Representatives
Victoria Friedman Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 1Class 5Class 29Class 30Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for industrialscientificagricultural and forestry purposeschemicals for use in the chemicalplasticsmetallurgicalglasspaperceramicsphotographyagriculturalhorticulturalforestrycommercial and residential buildingconstructionautomobileautomotiveinsulationpackagingengineeringenergyelectronicspharmaceuticalcosmeticfragrancetextileleathersynthetic rubberhealthcarepersonal carefoodpaintmould makingsemi-conductormicrochip and terrestrial photovoltaic industriesbiochemical and biotechnological products for industrialscientificagricultural and forestry purposeschemicals for use in biotechnological product development and biotechnological manufacturing processes; oligosaccharides and polysaccharides and derivatives thereof being unprocessed oligomers and polymers for industrial purposes; cyclodextrins and cyclodextrin derivatives for industrial use; chemical compositions containing cyclodextrins and cyclodextrin derivativeseither alone or in combinationfor general purpose in the cosmetichealthcarepharmaceuticalpersonal carefood and beverage industries; chemical solutionsdispersions and emulsions containing cyclodextrins and cyclodextrin derivativeseither alone or in combinationfor use in the manufacture of a wide variety of goods; raw materials being antioxidantsphenolsvitaminsessential oilsphytochemicalsfatsproteins and carbohydrates in raw material formactive substances being active chemical ingredients for use in the manufacture of medical and pharmaceutical preparations; enzymes for industrial purposes and enzyme preparations for general industrial use in the cosmetichealthcarepharmaceuticalpersonal carefood and beverage industry; enzymes and enzyme preparations for the food industry; cyclodextrins and derivatives thereof for foodstuffs and dietetic foodstuffs and in the form of process aids for the food industry and the dietetic food industry; raw materials being antioxidantsphenolsvitaminsessential oilsphytochemicalsfatsproteins and carbohydrates in raw material formactive substances being active chemical ingredients for foodstuffs and beverages; cyclodextrins and cyclodextrin derivatives for use in the manufacture of foodstuffs and beverages and dietary food supplements; phenols and derivatives thereof for industrial purposes; antioxidants for use in manufacture of a wide variety of goods; all of the aforementioned goods with the exception of diagnostic preparations for scientific use
Class 5
Pharmaceutical preparationsoligosaccharides and polysaccharides and derivatives thereof used as auxiliaries and additives and as carriersall being an integral component in pharmaceutical preparations for treatment of infectious diseasesinjuriesdegenerative conditionstumormental illnessespsychosomatic illnessesdiseases of civilizationvenereal diseasescardiovascular system diseasesgastroenteric system diseasesrespiratory system diseasesimmune and endocrine system diseasesnervous system diseasesviral diseasesdiabetescancerAIDS and infectious diseasesimmune and autoimmune diseasesinflammatory diseasesobesitydeficienciesnutritionalcancer and inbornvitaminimmunological deficienciesscarswoundspainophthalmic diseases and conditionsfor use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by traumadisease or missing from birth as well as and in veterinary preparationspain relief medicationantioxidants and preparations for treatment of intestinal bacteria; cyclodextrins and cyclodextrin derivatives in the form of nutritional food additives for medicineshuman foodstuffs and foodstuffs for animals in the nature of processed food extracts derived from plants; biocides; cyclodextrins and derivatives thereof being chemical preparations for pharmaceutical and veterinary purposesmedicinal healthcare preparations featuring cyclodextrins and derivatives thereof for the prevention and treatment of infectious diseasesinjuriesdegenerative conditionstumormental illnessespsychosomatic illnessesdiseases of civilizationvenereal diseasescardiovascular system diseasesgastroenteric system diseasesrespiratory system diseasesimmune and endocrine system diseasesnervous system diseasesviral diseasesdiabetescancerAIDS and infectious diseasesimmune and autoimmune diseasesinflammatory diseasesdeficienciesnutritionalcancer and inbornvitaminimmunological deficienciesscarswoundspainophthalmic diseases and conditionsfor use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by traumadisease or missing from birth as well as and in veterinary preparationspain relief medicationantioxidants and preparations for treatment of intestinal bacteria; complexed oils for dietetic purposesessential oils; complexed oils for making food for babiesessential oils; complexed oil extracts for dietetic purposes in the form of dieting powder preparations to promote weight loss; dietetic foodstuffsspicesherbsmeatfishseafoodeggsegg productsmilkdairy productsfruitsvegetablesnutsgrainsbaby foodpet fooddrinksdietary food supplements for medical purposes; cyclodextrins and cyclodextrin derivatives being chemical preparations for dietetic purposes; chemical preparations containing phenols and derivatives thereof for medical and veterinary purposesfor treatment of infectious diseasesinjuriesdegenerative conditionstumormental illnessespsychosomatic illnessesdiseases of civilizationvenereal diseasescardiovascular system diseasesgastroenteric system diseasesrespiratory system diseasesimmune and endocrine system diseasesnervous system diseasesviral diseasesdiabetescancerAIDS and infectious diseasesimmune and autoimmune diseasesinflammatory diseasesobesitydeficienciesnutritionalcancer and inbornvitaminimmunological deficienciesscarswoundspainophthalmic diseases and conditionsfor use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by traumadisease or missing from birth; chemical preparations containing antioxidants for medical and veterinary purposesfor treatment of infectious diseasesinjuriesdegenerative conditionstumormental illnessespsychosomatic illnessesdiseases of civilizationvenereal diseasescardiovascular system diseasesgastroenteric system diseasesrespiratory system diseasesimmune and endocrine system diseasesnervous system diseasesviral diseasesdiabetescancerAIDS and infectious diseasesimmune and autoimmune diseasesinflammatory diseasesobesitydeficienciesnutritionalcancer and inbornvitaminimmunological deficienciesscarswoundspainophthalmic diseases and conditionsfor use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by traumadisease or missing from birth; dietary supplements containing antioxidants for medical and veterinary purposes; dietary supplements; dietary supplements containing phenols and derivatives thereof; dietary supplements containing antioxidants; dietary supplements containing complexed oils or fatsnot for medical purposes; dietary supplements containing cyclodextrins and cyclodextrin derivativesnot for medical purposes; all of the aforementioned goods with the exception of vaccinesantibioticsdiagnostic preparations for therapeuticmedical and veterinary usechemical reagents for therapeuticmedicalpharmaceutical and veterinary usebacteriological preparations for medical or veterinary use
Class 29
Dietetic foodstuffs based on complexed oils or fatsnot for medical purposesspicesherbsmeatprocessed fishprocessed seafoodeggsegg substitute productsmilkprocessed fruitsprocessed vegetablesprocessed nutsedible fatsedible oilspreparations for making soupsoy milkmilk of almonds for culinary purposesrice milkdrinks based on yoghurtdrinks based on milk; dietetic foodstuffsnot for medical purposesbased on proteinsfatsalbumen containing phenols or derivatives thereofantioxidantsmeatprocessed fishprocessed seafoodeggsegg substitute productsmilkprocessed fruitsprocessed vegetablesprocessed nuts; preservedfrozendried and cooked fruits and vegetables
Class 30
Foodstuffs based on cyclodextrins and cyclodextrin derivativesspicesprocessed herbsprocessed grainsproducts derived from cerealsprocessed cerealscereal bars and cereal-based snack food; dietetic additives for foodstuffsflavor enhancers used in food and beverage productsnatural sweetenersthickening agents for use in cookingspicesprocessed herbs all for culinary purposes not for industrial use; cyclodextrins and cyclodextrin derivatives in the form of fibres for making foodstuffsfood additives containing cyclodextrins and cyclodextrin derivatives for culinary purposesnot for industrial use; dietetic foodstuffs based on cyclodextrins and cyclodextrin derivatives for culinary purposesnot for medical and industrial purposesspicesprocessed herbsprocessed grainsproducts derived from cerealsprocessed cerealscereal bars and cereal-based snack food; dietetic foodstuffsnot for medical purposesbased on carbohydratesspicesprocessed herbsprocessed grainsproducts derived from cerealsprocessed cerealscereal bars and cereal-based snack food; edible ices; sugarhoneytreacle
Class 40
Foodstuff processing modificationmodification of foodstuffs with nutritional food additives; food processing treatment of foodstuffstreating of foodstuffs with nutritional food additives; processing of foodstuffs for food production; food preservation; food smoking
Publications
History of USPTO decisions and trademark events.
65 publications found
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
01/13/2026
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/10/2025
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
10/10/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/04/2025
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
07/22/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
07/21/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
07/21/2025
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
11/21/2024
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
11/21/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/13/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/06/2024
ES75
TEAS SECTION 71 & 15 RECEIVED
03/22/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/17/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/31/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/03/2018
FIMP
FINAL DISPOSITION PROCESSED
08/03/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/17/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
04/17/2018
TMBN
TTAB RELEASE CASE TO TRADEMARKS
03/14/2018
OP.T
OPPOSITION TERMINATED NO. 999999
03/14/2018
OP.D
OPPOSITION DISMISSED NO. 999999
03/14/2018
GPNX
NOTIFICATION PROCESSED BY IB
10/28/2017
RFNT
REFUSAL PROCESSED BY IB
09/29/2017
OP.I
OPPOSITION INSTITUTED NO. 999999
09/20/2017
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
09/11/2017
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
09/09/2017
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
08/10/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/11/2017
PUBO
PUBLISHED FOR OPPOSITION
07/11/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/21/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/21/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/21/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/05/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/18/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
05/17/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/17/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
05/17/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/17/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/15/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/15/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/12/2017
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/28/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/12/2017
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/12/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/06/2016
GNRT
NON-FINAL ACTION E-MAILED
12/06/2016
CNRT
NON-FINAL ACTION WRITTEN
12/06/2016
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/07/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/27/2016
GNSL
LETTER OF SUSPENSION E-MAILED
04/27/2016
CNSL
SUSPENSION LETTER WRITTEN
04/27/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/30/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/30/2016
ALIE
ASSIGNED TO LIE
03/29/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/16/2016
RFNT
REFUSAL PROCESSED BY IB
01/22/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/06/2016
RFRR
REFUSAL PROCESSED BY MPU
01/06/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/30/2015
CNRT
NON-FINAL ACTION WRITTEN
12/29/2015
DOCK
ASSIGNED TO EXAMINER
12/16/2015
MAFR
APPLICATION FILING RECEIPT MAILED
11/20/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/16/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/15/2015
Continuous trademark protection
Get notified about every new filing that threatens CAVACURMIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.